Innovation Spotlight: The Future of Business

A new partnership aims to de-risk large-scale AI for critical sectors by embedding elite hardware and cybersecurity into a unified transformation model.

Weight Watchers now offers the new Wegovy pill, a needle-free option, betting its future on combining powerful GLP-1 drugs with its classic support.

RxSight will showcase its unique post-surgery adjustable lens at J.P. Morgan, facing investor questions on growth in a competitive ophthalmology market.

TransLink partners with local tech firm Spare to modernize HandyDART, promising online booking and real-time tracking for thousands of riders.

Beyond great food, diners now expect clean air. Discover how invisible pollutants impact health and why investing in filtration is a recipe for success.

DAREU is set to unveil three high-performance peripherals at CES 2026, combining advanced magnetic switches with an aggressive global expansion strategy.

As Equity Bancshares preps its Q4 report, investors eye its M&A success, margin health, and 2026 guidance amid a complex economic landscape.

After a year of strong earnings and a key merger, Mercantile Bank's upcoming annual report is a critical indicator for investors and the regional economy.

Adlai Nortye licenses its promising pan-RAS cancer inhibitor to ASK Pharm for Greater China in a deal valued at up to $230 million.

After five years in limbo, Phoenix's iconic One Camelback tower has a new owner. See how Kinella Capital plans to finally complete the stalled project.

In a fierce biotech talent war, Senti Bio's new equity grant for a key hire signals a strategic push for its gene therapy pipeline amid market volatility.

As Applied Digital preps its Q2 results, investors watch to see if its multi-billion dollar contracts can quell market volatility and affirm its AI future.

Avocado giant Mission Produce sets a new course, naming a successor to its founder CEO and refreshing its board to navigate future global market demands.

An executive order accelerates moving cannabis to Schedule III, promising massive tax breaks for businesses but leaving advocates wanting more federal reform.

Dynatrace becomes a launch partner for Google's Gemini, embedding advanced observability directly into the next generation of agentic AI for developers and enterprises.

Leveraging a fleet of vintage F-104 jets, Starfighters Space raises $40M and goes public, aiming to disrupt the small satellite launch market.

A new FDA approval for an EGFR-mutated lung cancer therapy cuts treatment from hours to minutes, offering new hope and convenience for thousands of patients.

A new once-monthly, self-injected cholesterol drug gets FDA nod, offering more convenience and setting the stage for a major market push in China.

Following a radical pivot from biotech, AIxCrypto hires a legal head to tackle the complex compliance challenges at the intersection of AI and crypto.

VIAVI Solutions converts over $100 million in debt to stock, a strategic move to reduce leverage and prepay a major loan after a recent acquisition.